JP2024509282A5 - - Google Patents
Info
- Publication number
- JP2024509282A5 JP2024509282A5 JP2023555333A JP2023555333A JP2024509282A5 JP 2024509282 A5 JP2024509282 A5 JP 2024509282A5 JP 2023555333 A JP2023555333 A JP 2023555333A JP 2023555333 A JP2023555333 A JP 2023555333A JP 2024509282 A5 JP2024509282 A5 JP 2024509282A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- group
- substituted
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159383P | 2021-03-10 | 2021-03-10 | |
| US63/159,383 | 2021-03-10 | ||
| PCT/US2022/019658 WO2022192478A1 (en) | 2021-03-10 | 2022-03-10 | Bifunctional degraders of galactose-deficient immunoglobulins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509282A JP2024509282A (ja) | 2024-02-29 |
| JP2024509282A5 true JP2024509282A5 (cg-RX-API-DMAC10.html) | 2025-03-19 |
Family
ID=83227063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555333A Pending JP2024509282A (ja) | 2021-03-10 | 2022-03-10 | ガラクトース欠損免疫グロブリンの二官能性分解剤 |
Country Status (11)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12023553152A1 (en) * | 2021-05-17 | 2024-03-11 | Biohaven Therapeutics Ltd | Compositions including conjugated therapy enhancers |
| JP2024524614A (ja) | 2021-07-14 | 2024-07-05 | ライシア セラピューティクス, インコーポレイテッド | Asgpr細胞表面受容体結合化合物及びコンジュゲート |
| CN121038815A (zh) * | 2023-04-29 | 2025-11-28 | 拜奥海芬治疗学有限公司 | 半乳糖缺陷型免疫球蛋白的双功能降解剂 |
| WO2026083257A1 (en) | 2024-10-14 | 2026-04-23 | Biohaven Therapeutics Ltd. | Antigen-specific degraders of immunoglobulin a and their uses |
| WO2026120177A1 (en) | 2024-12-06 | 2026-06-11 | Ascendis Pharma A/S | Novel long-acting degrader conjugates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440191B2 (en) * | 2005-11-18 | 2013-05-14 | Tufts Medical Center | Clearance of abnormal IGA1 in IGA1 deposition diseases |
| DK2991683T3 (da) * | 2013-05-02 | 2019-11-04 | Glykos Finland Oy | Konjugater af et glykoprotein eller en glykan med en toksisk ladning |
| CA2946064C (en) * | 2014-02-21 | 2023-09-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Glycotargeting therapeutics |
| RU2696490C2 (ru) * | 2014-05-19 | 2019-08-02 | Пфайзер Инк. | Замещенные-6,8-диоксабицикло[3.2.1.]октан-2,3-диольные соединения в качестве агентов, нацеленных на ASGPR |
| CA3134610A1 (en) * | 2018-04-09 | 2019-10-17 | Yale University | Bifunctional small molecules to target the selective degradation of circulating proteins |
-
2022
- 2022-03-10 WO PCT/US2022/019658 patent/WO2022192478A1/en not_active Ceased
- 2022-03-10 US US18/548,113 patent/US20240309114A1/en not_active Abandoned
- 2022-03-10 CA CA3211335A patent/CA3211335A1/en active Pending
- 2022-03-10 KR KR1020237033102A patent/KR20230154900A/ko active Pending
- 2022-03-10 EP EP22767951.1A patent/EP4304579A4/en active Pending
- 2022-03-10 CN CN202280020292.8A patent/CN116997337A/zh active Pending
- 2022-03-10 BR BR112023017702A patent/BR112023017702A2/pt unknown
- 2022-03-10 MX MX2023010424A patent/MX2023010424A/es unknown
- 2022-03-10 AU AU2022232620A patent/AU2022232620A1/en active Pending
- 2022-03-10 IL IL305665A patent/IL305665A/en unknown
- 2022-03-10 JP JP2023555333A patent/JP2024509282A/ja active Pending
-
2026
- 2026-01-15 US US19/449,561 patent/US20260146106A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102227442B (zh) | Sars冠状病毒的细胞毒性t细胞表位肽及其用途 | |
| JP5537431B2 (ja) | ウイルス融合のインヒビターのコレステロール誘導体 | |
| TWI839055B (zh) | 聚乙二醇化的藥物-連接劑及其中間體 | |
| SA518391996B1 (ar) | نظائر عامل النمو الجلدي شبيه مجال أ ببدائل حمض دهني | |
| JP7089062B2 (ja) | 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Bclファミリーアンタゴニストであるホスホリジン | |
| CN117915956A (zh) | M6pr细胞表面受体结合化合物和缀合物 | |
| JP2024509282A (ja) | ガラクトース欠損免疫グロブリンの二官能性分解剤 | |
| Zhuang et al. | Robo4 vaccines induce antibodies that retard tumor growth | |
| CA3132994A1 (en) | Tlr4 and tlr7 ligand formulations as vaccine adjuvants | |
| CN114917358A (zh) | 用于治疗癌症和炎症性疾病的偶联物和前药 | |
| KR20220097921A (ko) | 인터루킨-22의 치료 유도체 | |
| JP2025186263A (ja) | Epi-x4系ペプチドおよびその誘導体 | |
| CN102232083B (zh) | 禽流感疫苗 | |
| CN117355340A (zh) | 缀合物及其制备方法和用途 | |
| ES2322253T3 (es) | Utilizacion de mezclas de lipopeptidos para la fabricacion de vacunas. | |
| JPH04506666A (ja) | ワクチンアジュバントとしてのlfa―3 | |
| WO2012050193A1 (ja) | エボラウイルスリポソームワクチン | |
| JP5930967B2 (ja) | C型肝炎ウイルスリポソームワクチン | |
| WO2018129618A1 (en) | An agent for promoting angiogenesis and methods and uses thereof | |
| CN118019547A (zh) | 热稳定脂质纳米粒子及其使用方法 | |
| CA3171449C (en) | Coronavirus therapeutics and treatment methods | |
| CA3171449A1 (en) | Coronavirus therapeutics and treatment methods | |
| AU2009344150B2 (en) | Immunogenic composition and uses thereof | |
| HK1236815A1 (en) | Conjugates and prodrugs for treating of cancer and inflammatory diseases |